Skip to main content

News

By Jeff Lagasse | 09:22 am | October 02, 2024
The potential return on investment from reducing these inequities could be enormous, a Deloitte analysis finds.
By Jeff Lagasse | 03:12 pm | October 01, 2024
Various forms of a potential separation are reportedly under consideration, though specifics remain unclear.
By Susan Morse | 11:19 am | October 01, 2024
The drugmaker says it believes the rebate model is legally permissible and needed to improve the integrity of the 340B program.
By Susan Morse | 11:05 am | October 01, 2024
The HELP Committee wanted to punish de la Torre for invoking his Fifth Amendment right, the lawsuit says.
By Jeff Lagasse | 10:27 am | October 01, 2024
UMC has been able to keep its ER open, but other services have been disrupted.
By Jeff Lagasse | 04:02 pm | September 30, 2024
An audit finds $7.8M in federal funds were claimed for enrollees who were incorrectly assigned to eligibility groups.
By Susan Morse | 11:09 am | September 30, 2024
The rebates paid by drug companies will be deposited into the Medicare Trust Fund.
By Jeff Lagasse | 10:43 am | September 30, 2024
Denial rates have steadily increased, with providers seeing rejection rates as high as 10% to 15%.
By Jeff Lagasse | 04:13 pm | September 27, 2024
The lower MA premiums are expected to drive enrollment to 35.7 million by 2025 - about 51% of all Medicare beneficiaries.
By Susan Morse | 03:48 pm | September 27, 2024
HHS is offering the tests to help prevent widespread infections this fall and winter.